Original articleClinical endoscopy: EditorialEndoscopic submucosal dissection for early gastric cancer in the West: the absolute but not final word
Clinical endoscopy: Editorial
Section snippets
Disclosure
Dr Yang is a consultant for Boston Scientific, US Endoscopy, and Lumendi. Dr Draganov is a consultant for Boston Scientific, Lumendi, and Olympus. The other author disclosed no financial relationships relevant to this publication.
References (11)
- et al.
Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications
Gastrointest Endosc
(2011) - et al.
The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis
Gastrointest Endosc
(2018) Japanese gastric cancer treatment guidelines 2014 (ver. 4)
Gastric Cancer
(2017)- et al.
Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer
Dig Endosc
(2016) - et al.
Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study
Gastric Cancer
(2018)
There are more references available in the full text version of this article.
Cited by (3)
Risk of lymph node metastasis in early gastric cancer for a Western population
2023, Journal of Surgical OncologyOverutilization of surgery for superficial gastric carcinoma in USA: Is it still the case in 2020?
2021, Endoscopy International Open
© 2019 by the American Society for Gastrointestinal Endoscopy